Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BLADDER-CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2716 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Friis, S; Nielsen, GL; Mellemkjaer, L; McLaughlin, JK; Thulstrup, AM; Blot, WJ; Lipworth, L; Vilstrup, H; Olsen, JH
      Cancer risk in persons receiving prescriptions for paracetamol: A Danish cohort study

      INTERNATIONAL JOURNAL OF CANCER
    2. Liu, HL; Gandour-Edwards, R; Lara, PN; White, RD; LaSalle, JM
      Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization

      CANCER JOURNAL
    3. Grasso, M; Torelli, F; Scannapieco, G; Franzoso, F; Lania, C
      Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2

      JOURNAL OF IMMUNOTHERAPY
    4. Herrera, LA; Ostrosky-Wegman, P
      De helminths play a role in carcinogenesis?

      TRENDS IN PARASITOLOGY
    5. Simms, MS; Perkins, AC; Price, MR; Scholfield, DP; Bishop, MC
      (99m)Technetium-C595 radioimmunoscintigraphy: a potential staging tool forbladder cancer

      BJU INTERNATIONAL
    6. Poulakis, V; Witzsch, U; De Vries, R; Altmannsberger, HM; Manyak, MJ; Becht, E
      A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results

      BJU INTERNATIONAL
    7. Saint, F; Patard, JJ; Muscatelli, BG; Belda, MAL; de Medina, SGD; Abbou, CC; Chopin, DK
      Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment

      BJU INTERNATIONAL
    8. Woodhams, SD; Greenwell, TJ; Smalley, T; Mundy, AR
      Factors causing variation in urinary N-nitrosamine levels in enterocystoplasties

      BJU INTERNATIONAL
    9. Shelley, MD; Kynaston, H; Court, J; Wilt, TJ; Coles, B; Burgon, K; Mason, MD
      A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer

      BJU INTERNATIONAL
    10. Goddard, JC; Sutton, CD; Berry, DP; O'Byrne, KJ; Kockelbergh, RC
      The use of microvessel density in assessing human urological tumours

      BJU INTERNATIONAL
    11. Hayes, MC; Birch, BR; Cooper, AJ; Primrose, JN
      Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1)

      BJU INTERNATIONAL
    12. Hughes, ODM; Perkins, AC; Frier, M; Wastie, ML; Denton, G; Price, MR; Denley, H; Bishop, MC
      Imaging for staging bladder cancer: a clinical study of (111)indium-labelled anti-MUC1 mucin intravenous monoclonal antibody C595

      BJU INTERNATIONAL
    13. Vainio, H
      Use of biomarkers in risk assessment

      INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
    14. Au, WW
      Life style factors and acquired susceptibility to environmental disease

      INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
    15. Fujiwara, H; Emi, M; Nagai, H; Ohgaki, K; Imoto, I; Akimoto, M; Ogawa, O; Habuchi, T
      Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line

      JOURNAL OF HUMAN GENETICS
    16. Viswanathan, M; Tsuchida, N; Shanmugam, G
      Selective deletion of p14(ARF) exon 1 beta of the INK4a locus in oral squamous cell carcinomas of Indians

      ORAL ONCOLOGY
    17. Imai, Y; Sasaki, T; Fujibayashi, T
      Volume-corrected mitotic index as a prognostic factor in oral squamous cell carcinomas

      ORAL ONCOLOGY
    18. Knowles, MA
      What we could do now: molecular pathology of bladder cancer

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    19. Shochina, M; Fellig, Y; Sughayer, M; Pizov, G; Vitner, K; Podeh, D; Hochberg, A; Ariel, I
      Nitric oxide synthase immunoreactivity in human bladder carcinoma

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    20. Irwin, MS; Kaelin, WG
      Role of the newer p53 family proteins in malignancy

      APOPTOSIS
    21. Zeegers, MPA; Swaen, GMH; Kant, I; Goldbohm, RA; van den Brandt, PA
      Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands

      OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    22. Billerey, C; Sibony, M; Chopin, D; Gattegno, B
      Pathology

      PROGRES EN UROLOGIE
    23. Chopin, D; Gattegno, B; Cappellen, D; Radvanyi, F
      Oncogenes

      PROGRES EN UROLOGIE
    24. Chopin, D; Gattegno, B
      Descriptive epidemiology

      PROGRES EN UROLOGIE
    25. Gattegno, B; Chopin, D
      Natural history

      PROGRES EN UROLOGIE
    26. Gattegno, B; Chopin, D
      Diagnosis

      PROGRES EN UROLOGIE
    27. Gattegno, B; Chopin, D
      Local staging

      PROGRES EN UROLOGIE
    28. Chopin, D; Gattegno, B
      Intravesical chemotherapy

      PROGRES EN UROLOGIE
    29. Chopin, D; Saint, F; Gattegno, B
      Intravesical immunotherapy/bacille Calmette-Guerin

      PROGRES EN UROLOGIE
    30. Gattegno, B; Chopin, D
      Photodynamic therapy

      PROGRES EN UROLOGIE
    31. Gattegno, B; Chopin, D
      Cystectomy

      PROGRES EN UROLOGIE
    32. Gattegno, B; Chopin, D
      Surveillance

      PROGRES EN UROLOGIE
    33. Saint, F; Irani, J; Salomon, L; Debois, H; Abbou, CC; Chopin, D
      Study of the safety and efficacy of maintenance treatment with intravesical BCG instillation in the prevention of superficial bladder tumours.

      PROGRES EN UROLOGIE
    34. Debois, H; Loupi, E; Saliou, P; Blangy, H; Loeuille, D; Gillet, P
      Evaluation of the safety of intravesical BCG therapy in France: analysis of serious adverse events notified over a three-year period.

      PROGRES EN UROLOGIE
    35. Lachand, AT; Texier, J; Texier, P
      Surveillance and prognosis of stage Ta superficial bladder cancers. A homogeneous series of 138 cases followed for 1 to 18 years

      PROGRES EN UROLOGIE
    36. Lachand, AT; Texier, J; Texier, P
      Surveillance and prognosis of stage T1 superficial bladder tumours. A homogeneous series of 89 cases followed for 1 to 22 years.

      PROGRES EN UROLOGIE
    37. Torti, VR; Cobb, AJ; Everitt, JI; Marshall, MW; Boorman, GA; Butterworth, BE
      Nephrotoxicity and hepatotoxicity induced by inhaled bromodichloromethane in wild-type and p53-heterozygous mice

      TOXICOLOGICAL SCIENCES
    38. Lloyd, AC; Cackette, TA
      Diesel engines: Environmental impact and control

      JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION
    39. Wittel, UA; Goel, A; Varshney, GC; Batra, SK
      Mucin antibodies - New tools in diagnosis and therapy of cancer

      FRONTIERS IN BIOSCIENCE
    40. Crombet, T; Torres, O; Neninger, E; Catala, M; Rodriguez, N; Ramos, M; Fernandez, E; Iznaga, N; Perez, R; Lage, A
      Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    41. Larsson, PCM; Beheshti, B; Sampson, HA; Jewett, MAS; Shipman, R
      Allelic deletion fingerprinting of urine cell sediments in bladder cancer

      MOLECULAR DIAGNOSIS
    42. Lange, N; Vaucher, L; Marti, A; Etter, AL; Gerber, P; van den Bergh, H; Jichlinski, P; Kucera, P
      Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia

      JOURNAL OF BIOMEDICAL OPTICS
    43. Kiechle, FL; Gauss, I; Sykes, E
      Point-of-care testing: Body fluids

      JOURNAL OF CLINICAL LIGAND ASSAY
    44. Wieder, J; Freedland, SJ; Pantuck, AJ; Zisman, A; Belldegrun, AS
      Update on gene and immune based therapy for urologic malignancy

      UROLOGIC ONCOLOGY
    45. Leach, FS
      Molecular genetics of urothelial malignancies: Mismatch repair genes as markers for detection and prognosis?

      UROLOGIC ONCOLOGY
    46. Herr, HW; Donat, SM; Bajorin, DF
      Bladder cancer, the limits of surgical excision - when/how much?

      UROLOGIC ONCOLOGY
    47. Abdel-Salam, IM; Khaled, HM; Gaballah, HE; Mansour, OM; Kassem, HAA; Metwaly, AM
      Telomerase activity in bilharzial bladder cancer: Prognostic implications

      UROLOGIC ONCOLOGY
    48. McGarvey, TW; Meng, RD; Johnson, O; El-Deiry, W; Malkowicz, SB
      Growth inhibitory effect of p21 and p53 containing adenoviruses on transitional cell carcinoma cell lines in vitro and in vivo

      UROLOGIC ONCOLOGY
    49. Perabo, FGE; Mattes, RH; Wirger, A; Steiner, G; Kamp, S; Schmidt, D; Pegelow, K; von Ruecker, A; Muller, SC
      Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo

      UROLOGIC ONCOLOGY
    50. Hoshi, S; Ono, K; Suzuki, K; Ohyama, C; Namima, T; Orikasa, S
      Trans-urethral whole layer core biopsy for detection of residual tumor after neoadjuvant therapy in invasive bladder cancer

      UROLOGIC ONCOLOGY
    51. Dogra, PN; Kumar, R; Goel, A
      Non-invasive bladder cancer presenting with renal failure

      UROLOGIC ONCOLOGY
    52. Li, NC; Kanda, K; Fukumori, T; Inoue, Y; Nishitani, M; Kanayama, H; Kagawa, S
      Expression of vascular endothelial growth factor isoforms and platelet-derived endothelial cell growth factor in bladder cancer

      UROLOGIC ONCOLOGY
    53. Osman, I; Scher, HI; Drobnjak, M; Verbel, D; Morris, M; Agus, D; Ross, JS; Cordon-Cardo, C
      HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer

      CLINICAL CANCER RESEARCH
    54. Momoi, H; Okabe, H; Kamikawa, T; Satoh, S; Ikai, I; Yamamoto, M; Nakagawara, A; Shimahara, Y; Yamaoka, Y; Fukumoto, M
      Comprehensive allelotyping of human intrahepatic cholangiocarcinoma

      CLINICAL CANCER RESEARCH
    55. Dalbagni, G; Ren, ZP; Herr, H; Cordon-Cardo, C; Reuter, V
      Genetic alterations in TP53 in recurrent urothelial cancer: A longitudinalstudy

      CLINICAL CANCER RESEARCH
    56. Schmalfeldt, B; Prechtel, D; Harting, K; Spathe, K; Rutke, S; Konik, E; Fridman, R; Berger, U; Schmitt, M; Kuhn, W; Lengyel, E
      Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer

      CLINICAL CANCER RESEARCH
    57. Spafford, MF; Koch, WM; Reed, AL; Califano, JA; Xu, LH; Eisenberger, CF; Yip, L; Leong, PL; Wu, L; Liu, SXX; Jeronimo, C; Westra, WH; Sidransky, D
      Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis

      CLINICAL CANCER RESEARCH
    58. Davies, G; Jiang, WG; Mason, MD
      Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: A key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion

      CLINICAL CANCER RESEARCH
    59. Lamba, AB; Ward, MH; Weeks, JL; Dosemeci, M
      Cancer mortality patterns among hairdressers and barbers in 24 US states, 1984 to 1995

      JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    60. Siren, AL; McCarron, R; Wang, L; Garcia-Pinto, P; Ruetzler, C; Martin, D; Hallenbeck, JM
      Proinflammatory cytokine expression contributes to brain injury provoked by chronic monocyte activation

      MOLECULAR MEDICINE
    61. Ross, JS; Cohen, MB
      Biomarkers for the detection of bladder cancer

      ADVANCES IN ANATOMIC PATHOLOGY
    62. Terada, R; Yasutake, T; Nakamura, S; Hisamatsu, T; Nakagoe, T; Ayabe, H; Tagawa, Y
      Evaluation of metastatic potential of gastric tumors by staining for proliferating cell nuclear antigen and chromosome 17 numerical aberrations

      ANNALS OF SURGICAL ONCOLOGY
    63. Nakopoulou, L; Gakiopoulou, H; Zervas, A; Giannopoulou, I; Constantinides, C; Lazaris, AC; Liapis, H; Kyriakou, G; Dimopoulos, C
      MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: A comparison with clinicopathologic features and survival

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    64. Baty, V; Ray-Coquard, I; Roman, S; Bory, RM
      BCG therapy-related death and previous pelvic radiation

      ANNALS OF PHARMACOTHERAPY
    65. Gontijo, AMDC; Elias, FN; Salvadori, DMF; de Oliveira, MLCS; Correa, LA; Goldberg, J; Trindade, JCD; de Camargo, JLV
      Single-cell gel (comet) assay detects primary DNA damage in nonneoplastic urothelial cells of smokers and ex-smokers

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    66. Zeegers, MPA; Goldbohm, RA; van den Brandt, PA
      Consumption of vegetables and fruits and urothelial cancer incidence: a prospective study

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    67. Rolfe, KJ; Crow, JC; Benjamin, E; Reid, WMN; Maclean, AB; Perrett, CW
      Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    68. Michaud, DS; Clinton, SK; Rimm, EB; Willett, WC; Giovannucci, E
      Risk of bladder cancer by geographic region in a US cohort of male health professionals

      EPIDEMIOLOGY
    69. Greenberg, RS; Mandel, JS; Pastides, H; Britton, NL; Rudenko, L; Starr, TB
      A meta-analysis of cohort studies describing mortality and cancer incidence among chemical workers in the United States and western Europe

      EPIDEMIOLOGY
    70. Tang, KY; Lu, T; Chang, CH; Lo, YK; Cheng, JS; Wang, JL; Chang, HT; Jan, CR
      Effect of fluoxetine on intracellular Ca2+ levels in bladder female transitional carcinoma (BFTC) cells

      PHARMACOLOGICAL RESEARCH
    71. Cohen, PA; Peng, LM; Kjaergaard, J; Plautz, GE; Finke, JH; Koski, GK; Czerniecki, BJ; Shu, SY
      T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance

      CRITICAL REVIEWS IN IMMUNOLOGY
    72. Kleef, R; Jonas, WB; Knogler, W; Stenzinger, W
      Fever, cancer incidence and spontaneous remissions

      NEUROIMMUNOMODULATION
    73. Hayashi, H; Kuwahara, M; Fujisaki, N; Furihata, M; Ohtsuki, Y; Kagawa, S
      Immunohistochemical findings of nitric oxide synthase expression in urothelial transitional cell carcinoma including dysplasia

      ONCOLOGY REPORTS
    74. Inoue, K; Wood, CG; Slaton, JW; Karashima, T; Sweeney, P; Dinney, CPN
      Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8

      ONCOLOGY REPORTS
    75. Cindolo, L; Benincasa, G; Autorino, R; Domizio, S; De Rosa, G; Testa, G; D'Armiento, M; Altieri, V
      Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: A retrospective study

      ONCOLOGY REPORTS
    76. Satoh, M; Ito, A; Nojiri, H; Handa, K; Numahata, K; Ohyama, C; Saito, S; Hoshi, S; Hakomori, SI
      Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    77. Schaffer, AA; Simon, R; Desper, R; Richter, J; Sauter, G
      Tree models for dependent copy number changes in bladder cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    78. Louhelainen, J; Wijstrom, H; Hemminki, K
      Multiple regions with allelic loss at chromosome 3 in superficial multifocal bladder tumors

      INTERNATIONAL JOURNAL OF ONCOLOGY
    79. Wolf, HK; Stober, C; Hohenfellner, R; Leissner, J
      Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas

      TUMOR BIOLOGY
    80. Koga, S; Kondo, Y; Komata, T; Kondo, S
      Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisensetelomerase RNA

      GENE THERAPY
    81. Tanaka, M; Fraizer, GC; De la Cerda, J; Cristiano, RJ; Liebert, M; Grossman, HB
      Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery

      GENE THERAPY
    82. Lawrencia, C; Mahendran, R; Esuvaranathan, K
      Transfection of urothelial cells using methyl-beta-cyclodextrin solubilized cholesterol and Dotap

      GENE THERAPY
    83. Godschalk, RWL; Dallinga, JW; Wikman, H; Risch, A; Kleinjans, JCS; Bartsch, H; Van Schooten, FJ
      Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1, GSTT1, NAT1 and NAT2

      PHARMACOGENETICS
    84. Wikman, H; Thiel, S; Jager, B; Schmezer, P; Spiegelhalder, B; Edler, L; Dienemann, H; Kayser, K; Schulz, V; Drings, P; Bartsch, H; Risch, A
      Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility

      PHARMACOGENETICS
    85. Vaziri, SAJ; Hughes, NC; Sampson, H; Darlington, G; Jewett, MAS; Grant, DM
      Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects

      PHARMACOGENETICS
    86. Balbi, JC; Larrinaga, MT; De Stefani, E; Mendilaharsu, M; Ronco, AL; Boffetta, P; Brennan, P
      Foods and risk of bladder cancer: a case-control study in Uruguay

      EUROPEAN JOURNAL OF CANCER PREVENTION
    87. Mizutani, Y; Wada, H; Fukushima, M; Yoshida, O; Ukimura, O; Kawauchi, A; Miki, T
      The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer

      EUROPEAN JOURNAL OF CANCER
    88. Kido, S; Kitadai, Y; Hattori, N; Haruma, K; Kido, T; Ohta, M; Tanaka, S; Yoshihara, M; Sumii, K; Ohmoto, Y; Chayama, K
      Interleukin 8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas?

      EUROPEAN JOURNAL OF CANCER
    89. Forsti, A; Louhelainen, J; Soderberg, M; Wijkstrom, H; Hemminki, K
      Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer

      EUROPEAN JOURNAL OF CANCER
    90. Su, SJ; Lai, MD; Yeh, TM; Chow, NH
      Overexpression of HER-2/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones

      EUROPEAN JOURNAL OF CANCER
    91. Peto, J; Houlston, RS
      Genetics and the common cancers

      EUROPEAN JOURNAL OF CANCER
    92. Nishino, Y; Tsubono, Y; Tsuji, I; Komatsu, S; Kanemura, S; Nakatsuka, H; Fukao, A; Satoh, H; Hisamichi, S
      Passive smoking at home and cancer risk: a population-based prospective study in Japanese nonsmoking women

      CANCER CAUSES & CONTROL
    93. Brennan, P; Bogillot, O; Greiser, E; Chang-Claude, J; Wahrendorf, J; Cordier, S; Jockel, KH; Lopez-Abente, G; Tzonou, A; Vineis, P; Donato, F; Hours, M; Serra, C; Bolm-Audorff, U; Schill, W; Kogevinas, M; Boffetta, P
      The contribution of cigarette smoking to bladder cancer in women (pooled European data)

      CANCER CAUSES & CONTROL
    94. Boffetta, P; Dosemeci, M; Gridley, G; Bath, H; Moradi, T; Silverman, D
      Occupational exposure to diesel engine emissions and risk of cancer in Swedish men and women

      CANCER CAUSES & CONTROL
    95. Terry, P; Terry, JB; Wolk, A
      Fruit and vegetable consumption in the prevention of cancer: an update

      JOURNAL OF INTERNAL MEDICINE
    96. Vikhanskaya, F; Bani, MR; Borsotti, P; Ghilardi, C; Ceruti, R; Ghisleni, G; Marabese, M; Giavazzi, R; Broggini, M; Taraboletti, G
      p73 overexpression increases VEGF and reduces thrombospondin-1 production:implications for tumor angiogenesis

      ONCOGENE
    97. Tarapore, P; Tokuyama, Y; Horn, HF; Fukasawa, K
      Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53

      ONCOGENE
    98. Habuchi, T; Takahashi, T; Kakinuma, H; Wang, LZ; Tsuchiya, N; Satoh, S; Akao, T; Sato, K; Ogawa, O; Knowles, MA; Kato, T
      Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer

      ONCOGENE
    99. Jeronimo, C; Nomoto, S; Caballero, OL; Usadel, H; Henrique, R; Varzim, G; Oliveira, J; Lopes, C; Fliss, MS; Sidransky, D
      Mitochondrial mutations in early stage prostate cancer and bodily fluids

      ONCOGENE
    100. Yoon, DS; Li, L; Zhang, RD; Kram, A; Ro, JY; Johnston, D; Grossman, HB; Scherer, S; Czerniak, B
      Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease

      ONCOGENE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 16:04:03